Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus
Lysocin E is a lipopeptide with antibiotic activity against methicillin-resistant Staphylococcus aureus. Here, the authors show that the antimicrobial activity of lysocin E is potentiated through interactions with host serum proteins (such as apolipoprotein A-I) and bacterial membrane components.
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b0d96c9f5e974962964e3a02e7b2c23b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b0d96c9f5e974962964e3a02e7b2c23b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b0d96c9f5e974962964e3a02e7b2c23b2021-11-08T11:06:35ZSerum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus10.1038/s41467-021-26702-02041-1723https://doaj.org/article/b0d96c9f5e974962964e3a02e7b2c23b2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-26702-0https://doaj.org/toc/2041-1723Lysocin E is a lipopeptide with antibiotic activity against methicillin-resistant Staphylococcus aureus. Here, the authors show that the antimicrobial activity of lysocin E is potentiated through interactions with host serum proteins (such as apolipoprotein A-I) and bacterial membrane components.Hiroshi HamamotoSuresh PantheeAtmika PaudelKenichi IshiiJyunichiro YasukawaJie SuAtsushi MiyashitaHiroaki ItohKotaro TokumotoMasayuki InoueKazuhisa SekimizuNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Hiroshi Hamamoto Suresh Panthee Atmika Paudel Kenichi Ishii Jyunichiro Yasukawa Jie Su Atsushi Miyashita Hiroaki Itoh Kotaro Tokumoto Masayuki Inoue Kazuhisa Sekimizu Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus |
description |
Lysocin E is a lipopeptide with antibiotic activity against methicillin-resistant Staphylococcus aureus. Here, the authors show that the antimicrobial activity of lysocin E is potentiated through interactions with host serum proteins (such as apolipoprotein A-I) and bacterial membrane components. |
format |
article |
author |
Hiroshi Hamamoto Suresh Panthee Atmika Paudel Kenichi Ishii Jyunichiro Yasukawa Jie Su Atsushi Miyashita Hiroaki Itoh Kotaro Tokumoto Masayuki Inoue Kazuhisa Sekimizu |
author_facet |
Hiroshi Hamamoto Suresh Panthee Atmika Paudel Kenichi Ishii Jyunichiro Yasukawa Jie Su Atsushi Miyashita Hiroaki Itoh Kotaro Tokumoto Masayuki Inoue Kazuhisa Sekimizu |
author_sort |
Hiroshi Hamamoto |
title |
Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus |
title_short |
Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus |
title_full |
Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus |
title_fullStr |
Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus |
title_full_unstemmed |
Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus |
title_sort |
serum apolipoprotein a-i potentiates the therapeutic efficacy of lysocin e against staphylococcus aureus |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/b0d96c9f5e974962964e3a02e7b2c23b |
work_keys_str_mv |
AT hiroshihamamoto serumapolipoproteinaipotentiatesthetherapeuticefficacyoflysocineagainststaphylococcusaureus AT sureshpanthee serumapolipoproteinaipotentiatesthetherapeuticefficacyoflysocineagainststaphylococcusaureus AT atmikapaudel serumapolipoproteinaipotentiatesthetherapeuticefficacyoflysocineagainststaphylococcusaureus AT kenichiishii serumapolipoproteinaipotentiatesthetherapeuticefficacyoflysocineagainststaphylococcusaureus AT jyunichiroyasukawa serumapolipoproteinaipotentiatesthetherapeuticefficacyoflysocineagainststaphylococcusaureus AT jiesu serumapolipoproteinaipotentiatesthetherapeuticefficacyoflysocineagainststaphylococcusaureus AT atsushimiyashita serumapolipoproteinaipotentiatesthetherapeuticefficacyoflysocineagainststaphylococcusaureus AT hiroakiitoh serumapolipoproteinaipotentiatesthetherapeuticefficacyoflysocineagainststaphylococcusaureus AT kotarotokumoto serumapolipoproteinaipotentiatesthetherapeuticefficacyoflysocineagainststaphylococcusaureus AT masayukiinoue serumapolipoproteinaipotentiatesthetherapeuticefficacyoflysocineagainststaphylococcusaureus AT kazuhisasekimizu serumapolipoproteinaipotentiatesthetherapeuticefficacyoflysocineagainststaphylococcusaureus |
_version_ |
1718442366407278592 |